VALLON PHARMACEUTICALS INC (VLON) Stock Analyst Earnings Estimates
NASDAQ:VLON - Nasdaq - US92023M1018 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2018 | 2019 | 2020 | 2021 | 2022 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 100K | -100.00% | N/A | |||
| EBITDA YoY % growth | -4.31M | -3.13M 27.38% | -4.71M -50.48% | N/A -94.78% | N/A 26.73% | |
| EBIT YoY % growth | -4.31M | -3.15M 26.91% | -4.79M -52.06% | -7.818M -93.30% | N/A 25.18% | |
| Operating Margin | N/A | N/A | -4,790.00% | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -1.20 | N/A |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2022 Q2Q % growth | -0.20 41.18% | -0.23 | 0.03 | 14.75% |
| Q1 2022 Q2Q % growth | -0.39 15.22% | -0.22 | -0.17 | -73.80% |
| Q4 2021 Q2Q % growth | -0.46 | -0.22 | -0.24 | -104.99% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2021 Q2Q % growth | -100.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |